These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9516418)

  • 1. A peptide derived from a conserved domain of Sendai virus fusion protein inhibits virus-cell fusion. A plausible mode of action.
    Ghosh JK; Shai Y
    J Biol Chem; 1998 Mar; 273(13):7252-9. PubMed ID: 9516418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion.
    Ghosh JK; Peisajovich SG; Ovadia M; Shai Y
    J Biol Chem; 1998 Oct; 273(42):27182-90. PubMed ID: 9765238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.
    Ghosh JK; Peisajovich SG; Shai Y
    Biochemistry; 2000 Sep; 39(38):11581-92. PubMed ID: 10995225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus.
    Ghosh JK; Ovadia M; Shai Y
    Biochemistry; 1997 Dec; 36(49):15451-62. PubMed ID: 9398274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.
    Samuel O; Shai Y
    Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
    Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion.
    Peisajovich SG; Samuel O; Shai Y
    J Mol Biol; 2000 Mar; 296(5):1353-65. PubMed ID: 10698638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-induced step in the activation of Sendai virus fusion protein.
    Ben-Efraim I; Kliger Y; Hermesh C; Shai Y
    J Mol Biol; 1999 Jan; 285(2):609-25. PubMed ID: 9878433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane destabilization by N-terminal peptides of viral envelope proteins.
    Düzgüneş N; Shavnin SA
    J Membr Biol; 1992 May; 128(1):71-80. PubMed ID: 1323686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses.
    Rapaport D; Ovadia M; Shai Y
    EMBO J; 1995 Nov; 14(22):5524-31. PubMed ID: 8521809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sendai virus N-terminal fusion peptide consists of two similar repeats, both of which contribute to membrane fusion.
    Peisajovich SG; Epand RF; Epand RM; Shai Y
    Eur J Biochem; 2002 Sep; 269(17):4342-50. PubMed ID: 12199713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Joshi SB; Dutch RE; Lamb RA
    Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.
    Young JK; Li D; Abramowitz MC; Morrison TG
    J Virol; 1999 Jul; 73(7):5945-56. PubMed ID: 10364347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of matrix and fusion proteins in budding of Sendai virus.
    Takimoto T; Murti KG; Bousse T; Scroggs RA; Portner A
    J Virol; 2001 Dec; 75(23):11384-91. PubMed ID: 11689619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions.
    Takimoto T; Bousse T; Coronel EC; Scroggs RA; Portner A
    J Virol; 1998 Dec; 72(12):9747-54. PubMed ID: 9811709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein.
    Monsma SA; Blissard GW
    J Virol; 1995 Apr; 69(4):2583-95. PubMed ID: 7533858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes.
    Rapaport D; Shai Y
    J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.